Robert Carroll, M.D.

Robert R Carroll, M.D.

(352) 273-7832

Current patients:
Log in to MyUFHealth

Publications

First and subsequent cycle use of pegfilgrastim prevents febrile neutropenia in patients with breast cancer: a multicenter, double-blind, placebo-controlled phase III study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
2005

Dose-intense ifosfamide/doxorubicin/cisplatin based chemotherapy for osteosarcoma in adults.
American journal of clinical oncology
2002

Squamous cell carcinoma of the anal canal.
International journal of radiation oncology, biology, physics
2001

Induction chemotherapy and radiation therapy for T4 oropharyngeal carcinoma.
Radiation oncology investigations
1999

Canebrake rattlesnake envenomation.
Annals of emergency medicine
1997

Current management of squamous cell carcinoma of the anal canal.
Surgical oncology
1994

Spontaneous disappearance of an IgA anti-factor IX inhibitor in a child with Christmas disease.
American journal of hematology
1984

Intravenous immunoglobulin administration in the treatment of severe chronic immune thrombocytopenic purpura.
The American journal of medicine
1984

High-dose intravenous immunoglobulin therapy in patients with immune thrombocytopenic purpura.
JAMA
1983

Hematuria unrelated to hemophilia in a hemophiliac.
Southern medical journal
1982

Research Interests

  • Dr. Carroll's interests include extensive clinical trials effort, genetic testing for abnormalities of BrCa1 and BrCa2, management of chemotherapy and hormonal treatments, and guidance and recommendations for breast cancer prevention in women who were at high risk for developing the disease.